COMP <GO>
GLW vs TMO // ENTERPRISE SCALE & MARKET CAP
Corning Incorporated (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: GLW 5
— TMO 10
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $123.31 (-4.32%) • MKT CAP: $111.02B
market-cap
$111.02B
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GLW VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GLW | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.00% | 41.00% | -5.00 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 9.30% | +0.60 | GLW | /roic <GO> |
| EV/EBITDA & P/E Valuation | 40.8x | 30.4x | +10.40 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 1.79% | 2.40% | -0.61 | TMO | /fcf-yield <GO> |
| Operating Margin | 14.60% | 17.40% | -2.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | 10.20% | 15.10% | -4.90 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 19.10% | 3.90% | +15.20 | GLW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.19 | 4.50 | +0.69 | GLW | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | GLW | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.70% | +0.30 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.9 | 59.1 | -23.21 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.94 | +0.08 | GLW | /macro-sensitivity <GO> |
| Forward P/E Multiple | 58.5x | 36.3x | +22.20 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $111.02B | $262.22B | -$151.20B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GLW REV | TMO REV | GLW GROSS % | TMO GROSS % | GLW FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $15.63B | $44.56B | 36.0% | 44.0% | $1.99B | $6.29B |
| FY 2024 | $13.12B | $42.88B | 32.6% | 44.0% | $1.35B | $7.27B |
| FY 2023 | $12.59B | $42.86B | 44.0% | 44.0% | $1.44B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GLW // BETA 1.02
TMO // BETA 0.94